Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer
Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer have?
Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer has 74 citations in the OpenAlex counts ScholarIQ stores.
When was Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer published?
Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer has 2008 year in the ScholarIQ index.
What is the open-access status of Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer?
Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer has hybrid oa status in the ScholarIQ index.
What is the DOI of Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer?
The DOI for Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer is on the source record.
What is the PMID of Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer?
The PMID for Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer is on the source record.
What is the OpenAlex record for Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer?
The OpenAlex for Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer is on the source record.